Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Residual breast tissue after mastectomy and reconstruction: A substudy of the Spatial location of breast cancer local rECurRence aftEr masTectomy (SECRET) project.
Kaidar-Person O, Sklair-Levy M, Anaby D, Bernstein-Molho R, van Maaren MC, de Munck L, de Ruysscher D, Offersen B, Poortmans P, Boersma LJ; SECRET group. Kaidar-Person O, et al. Among authors: poortmans p. Eur J Surg Oncol. 2024 Nov;50(11):108607. doi: 10.1016/j.ejso.2024.108607. Epub 2024 Aug 16. Eur J Surg Oncol. 2024. PMID: 39191132
Reducing interobserver variation of boost-CTV delineation in breast conserving radiation therapy using a pre-operative CT and delineation guidelines.
Boersma LJ, Janssen T, Elkhuizen PH, Poortmans P, van der Sangen M, Scholten AN, Hanbeukers B, Duppen JC, Hurkmans C, van Vliet C. Boersma LJ, et al. Among authors: poortmans p. Radiother Oncol. 2012 May;103(2):178-82. doi: 10.1016/j.radonc.2011.12.021. Epub 2012 Jan 20. Radiother Oncol. 2012. PMID: 22265730
Target volume delineation in external beam partial breast irradiation: less inter-observer variation with preoperative- compared to postoperative delineation.
van der Leij F, Elkhuizen PH, Janssen TM, Poortmans P, van der Sangen M, Scholten AN, van Vliet-Vroegindeweij C, Boersma LJ. van der Leij F, et al. Among authors: poortmans p. Radiother Oncol. 2014 Mar;110(3):467-70. doi: 10.1016/j.radonc.2013.10.033. Epub 2013 Nov 18. Radiother Oncol. 2014. PMID: 24262820
Radiotherapy for breast cancer, the TARGIT-A trial.
Yarnold J, Offersen BV, Olivotto I, Poortmans P, Sarin R. Yarnold J, et al. Among authors: poortmans p. Lancet. 2014 May 17;383(9930):1717-8. doi: 10.1016/S0140-6736(14)60828-X. Lancet. 2014. PMID: 24835611 No abstract available.
Haste makes waste: are the data regarding TARGIT-A IORT ready for prime time?
Kaidar-Person O, Poortmans P, Klimberg S, Haviland J, Offersen B, Audisio R, Yarnold J. Kaidar-Person O, et al. Among authors: poortmans p. Breast Cancer Res Treat. 2014 Aug;147(1):221-2. doi: 10.1007/s10549-014-3032-5. Epub 2014 Jul 22. Breast Cancer Res Treat. 2014. PMID: 25048466 No abstract available.
ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer.
Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Biete Sola A, Kirova YM, Pignol JP, Remouchamps V, Verhoeven K, Weltens C, Arenas M, Gabrys D, Kopek N, Krause M, Lundstedt D, Marinko T, Montero A, Yarnold J, Poortmans P. Offersen BV, et al. Among authors: poortmans p. Radiother Oncol. 2015 Jan;114(1):3-10. doi: 10.1016/j.radonc.2014.11.030. Epub 2015 Jan 24. Radiother Oncol. 2015. PMID: 25630428
Radiotherapy for elderly patients with low-risk breast cancer.
Kaidar-Person O, Poortmans P, Kuten A, Morgan DA. Kaidar-Person O, et al. Among authors: poortmans p. Lancet Oncol. 2015 May;16(5):e196-7. doi: 10.1016/S1470-2045(15)70063-X. Lancet Oncol. 2015. PMID: 25943058 No abstract available.
ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1.
Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Sola AB, Kirova YM, Pignol JP, Remouchamps V, Verhoeven K, Weltens C, Arenas M, Gabrys D, Kopek N, Krause M, Lundstedt D, Marinko T, Montero A, Yarnold J, Poortmans P. Offersen BV, et al. Among authors: poortmans p. Radiother Oncol. 2016 Jan;118(1):205-8. doi: 10.1016/j.radonc.2015.12.027. Epub 2016 Jan 18. Radiother Oncol. 2016. PMID: 26791404 No abstract available.
Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial.
Brouwers PJ, van Werkhoven E, Bartelink H, Fourquet A, Lemanski C, van Loon J, Maduro JH, Russell NS, Scheijmans LJ, Schinagl DA, Westenberg AH, Poortmans P, Boersma LJ; Young Boost Trial research group. Brouwers PJ, et al. Among authors: poortmans p. Radiother Oncol. 2016 Jul;120(1):107-13. doi: 10.1016/j.radonc.2016.04.017. Epub 2016 May 28. Radiother Oncol. 2016. PMID: 27247055 Clinical Trial.
435 results